Clinical efficacy of in vitro local high-frequency hyperthermia combined with drugs in the treatment of type Ⅲb chronic prostatitis
10.3969/j.issn.1009-8291.2023.07.009
- VernacularTitle:体外局部高频热疗联合药物治疗Ⅲb型慢性前列腺炎的临床疗效观察
- Author:
Fengqi YAN
1
;
Hua LAN
1
;
Dali HE
1
;
Dong CUI
1
;
Bo ZHANG
1
;
Yong JIAO
1
Author Information
1. Department of Urology, The Second Affiliated Hospital of Air Force Medical University, Xi’an 710038, China
- Publication Type:Journal Article
- Keywords:
high-frequency hyperthermia;
medication type Ⅲb chronic prostatitis;
combined treatment;
NIH-CPSI scale;
IIEF-5 score
- From:
Journal of Modern Urology
2023;28(7):588-590
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To investigate the efficacy of in vitro local high-frequency hyperthermia combined with drugs in the treatment of type Ⅲb chronic prostatitis (CP). 【Methods】 A total of 148 patients with type Ⅲb CP treated in our hospital during Jun.2020 and Jun.2022 were randomly divided into control group (n=74) and combination group (n=74). The control group received only drug treatment, while the combination group received extracorporeal local high-frequency hyperthermia treatment. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), maximum urinary flow rate (MFR), average urinary flow rate (AFR) and International Index of Erectile Function-5 (IIEF-5) score were compared between the two groups. 【Results】 There were no significant differences between the two groups in terms of NIH-CPSI, MFR, AFR and IIEF-5 score before treatment(P>0.05). After treatment, these indexes increased in both groups (P<0.05), and the improvements in the combination group were more significant (P<0.05). 【Conclusion】 Medication combined with in vitro local high-frequency hyperthermia is effective in improving the clinical symptoms of type Ⅲb CP, which is worth clinical promotion.
